From ASCO 2020: analysis by Daniel P. Petrylak, MD, and Elizabeth R. Plimack, MD, MS, of key studies in renal cell carcinoma, urothelial carcinoma, and prostate cancer from CCO
From Clinical Care Options (CCO), an on-demand Webcast on immuno-oncology biomarkers that are key to optimal cancer treatment across multiple tumors
From Clinical Care Options (CCO), watch video of an expert discussion of NTRK fusion testing and TRK inhibitor use in solid cancers
From Clinical Care Options (CCO), video featuring expert presentations on the role of PARP inhibition in the treatment of prostate cancer
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.